G. Walsh
Molecular Biology · 2000–2018
A researcher in the Science corpus: 6 papers; trusts 2 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 10 citations into it; #13,165 of 17,773 by trust here, #13,891 by citations
Whom G. Walsh trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts G. Walsh overall
Papers from G. Walsh's perspective
Ordered by how strongly the researchers G. Walsh trusts endorse each paper. Same corpus, a different order for every researcher.
- PEGylation, successful approach to drug delivery. (Drug Discovery Today)
- The biology of chemokines and their receptors. (Annual Review of Immunology)
- Pegylation: a novel process for modifying pharmacokinetics. (Clinical Pharmacokinetics)
- Chemistry for peptide and protein PEGylation. (Advanced Drug Delivery Reviews)
- Direct conversion of fibroblasts to functional neurons by defined factors (Nature)
- Post-translational modifications in the context of therapeutic proteins (Nature Biotechnology)
- Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
- The mammalian epigenome. (Cell)
- Translating the Histone Code (Science)
- CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia (Science Translational Medicine)
Their papers
- Biopharmaceutical benchmarks (2000) — 767 citations
- Biopharmaceutical benchmarks 2018 (2018) — 850 citations
- Biopharmaceutical benchmarks 2014 (2014) — 898 citations
- Biopharmaceutical benchmarks 2010 (2010) — 912 citations
- Post-translational modifications in the context of therapeutic proteins (2006) — 968 citations
- Proteins: Biochemistry and Biotechnology (2001) — 184 citations